Janney Montgomery Scott LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.

Quarter-by-quarter ownership
Janney Montgomery Scott LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$2,738
+1085.3%
22,584
+1019.1%
0.01%
+900.0%
Q2 2023$231
-23.8%
2,018
-8.3%
0.00%0.0%
Q1 2023$303
-37.7%
2,201
-41.3%
0.00%
-50.0%
Q4 2022$486
-99.8%
3,749
+15.2%
0.00%
+100.0%
Q1 2022$254,000
-17.3%
3,253
-4.7%
0.00%0.0%
Q4 2021$307,000
+19.5%
3,414
+23.0%
0.00%0.0%
Q3 2021$257,000
-23.7%
2,776
-35.9%
0.00%0.0%
Q2 2021$337,000
+14.2%
4,334
+9.6%
0.00%0.0%
Q1 2021$295,000
-61.2%
3,954
-11.4%
0.00%
-75.0%
Q4 2020$761,000
+12.9%
4,465
-6.9%
0.00%0.0%
Q3 2020$674,000
-15.2%
4,798
-3.3%
0.00%
-20.0%
Q2 2020$795,000
+67.7%
4,961
+2.4%
0.01%
+25.0%
Q1 2020$474,000
-30.8%
4,844
-8.8%
0.00%0.0%
Q4 2019$685,000
+84.6%
5,312
+7.7%
0.00%
+33.3%
Q3 2019$371,000
-40.2%
4,930
+20.9%
0.00%
-40.0%
Q2 2019$620,000
+31.1%
4,078
+2.7%
0.01%
+25.0%
Q1 2019$473,000
+62.5%
3,969
+48.8%
0.00%
+33.3%
Q4 2018$291,000
-41.4%
2,667
-13.3%
0.00%
-25.0%
Q3 2018$497,000
+31.8%
3,077
+7.9%
0.00%0.0%
Q2 2018$377,000
-26.5%
2,852
-58.8%
0.00%
-20.0%
Q1 2018$513,000
-44.1%
6,920
-58.1%
0.01%
-50.0%
Q4 2017$918,000
+93.7%
16,507
+58.0%
0.01%
+100.0%
Q3 2017$474,000
+6.3%
10,445
-35.7%
0.01%
-28.6%
Q4 2016$446,00016,2460.01%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,400$35,962,0005.36%
Avoro Capital Advisors LLC 3,125,000$281,406,0004.79%
Varenne Capital Partners 324,661$29,236,0004.34%
Evolutionary Tree Capital Management, LLC 96,695$8,707,0004.18%
Ally Bridge Group (NY) LLC 120,000$10,806,0003.78%
Casdin Capital, LLC 1,350,000$121,568,0003.43%
Ghost Tree Capital, LLC 100,000$9,005,0003.23%
GREAT POINT PARTNERS LLC 145,405$13,094,0002.91%
Camber Capital Management LP 825,000$74,291,0002.55%
Alpha DNA Investment Management LLC 17,522$1,577,0001.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders